» Articles » PMID: 27073521

MiR-517a is an Independent Prognostic Marker and Contributes to Cell Migration and Invasion in Human Colorectal Cancer

Overview
Journal Oncol Lett
Specialty Oncology
Date 2016 Apr 14
PMID 27073521
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is a highly invasive tumor that is frequently associated with distant metastasis, which is the primary cause of poor prognosis. However, the mechanisms of metastasis remain poorly understood. MicroRNAs (miRNAs/miRs) have been considered to be implicated in CRC progression. In particular, miR-517a is proposed as a novel tumor-associated miRNA and has a potential role in tumor metastasis. The expression of miR-517a in CRC specimens was detected by reverse transcription-quantitative polymerase chain reaction. Transwell assays were performed to determine the migration and invasion of CRC cells. The putative target genes of miR-517a were disclosed using publicly available databases and western blot analysis. The present study identified that the expression of miR-517a was significantly higher in CRC tissues as compared with adjacent non-tumor tissues. Clinical analysis indicated that increased expression of miR-517a was correlated with poor prognostic features and poor long-term survival of CRC patients. evidences demonstrated that downregulation of miR-517a inhibited cell migration and invasion in HCT-116 cells. By contrast, upregulation of miR-517a increased the number of migrated and invaded SW480 cells. Notably, miR-517a expression was inversely regulated by forkhead box J3 (FOXJ3) abundance in CRC cells. Furthermore, an inverse correlation between miR-517a and FOXJ3 expression was observed in CRC tissues. In conclusion, miR-517a appears to be an independent prognostic marker for predicting survival of CRC patients, and may promote cell migration and invasion by inhibiting FOXJ3.

Citing Articles

The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer.

Torres-Bustamante M, Vazquez-Urrutia J, Solorzano-Ibarra F, Ortiz-Lazareno P Int J Mol Sci. 2024; 25(4).

PMID: 38396855 PMC: 10889402. DOI: 10.3390/ijms25042178.


Expression study of microRNA cluster on chromosome 19 (C19MC) in tumor tissue and serum of breast cancer patient.

Altalebi S, Haghi M, Feizi M Mol Biol Rep. 2023; 50(12):9825-9831.

PMID: 37840066 DOI: 10.1007/s11033-023-08801-x.


A Comprehensive Study on the Anti-cancer Effects of Quercetin and Its Epigenetic Modifications in Arresting Progression of Colon Cancer Cell Proliferation.

Bhatiya M, Pathak S, Jothimani G, Duttaroy A, Banerjee A Arch Immunol Ther Exp (Warsz). 2023; 71(1):6.

PMID: 36807774 PMC: 9941246. DOI: 10.1007/s00005-023-00669-w.


Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer.

Madrigal T, Hernandez-Monge J, Herrera L, Gonzalez-De la Rosa C, Dominguez-Gomez G, Candelaria M Front Cell Dev Biol. 2021; 9:695723.

PMID: 34957087 PMC: 8697023. DOI: 10.3389/fcell.2021.695723.


The miR-27a/FOXJ3 Axis Dysregulates Mitochondrial Homeostasis in Colorectal Cancer Cells.

Barisciano G, Leo M, Muccillo L, Pranzini E, Parri M, Colantuoni V Cancers (Basel). 2021; 13(19).

PMID: 34638478 PMC: 8507763. DOI: 10.3390/cancers13194994.


References
1.
Jin J, Zhou S, Li C, Xu R, Zu L, You J . MiR-517a-3p accelerates lung cancer cell proliferation and invasion through inhibiting FOXJ3 expression. Life Sci. 2014; 108(1):48-53. DOI: 10.1016/j.lfs.2014.05.006. View

2.
Colangelo T, Fucci A, Votino C, Sabatino L, Pancione M, Laudanna C . MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer. Neoplasia. 2013; 15(9):1086-99. PMC: 3769887. DOI: 10.1593/neo.13998. View

3.
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu C . microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer. 2014; 13:124. PMC: 4065091. DOI: 10.1186/1476-4598-13-124. View

4.
Wu W, Lee C, Cho C, Fan D, Wu K, Yu J . MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010; 29(43):5761-71. DOI: 10.1038/onc.2010.352. View

5.
Feng J, Kim S, Liu W, Kim J, Zhang Z, Zhu Y . An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma. Cancer. 2011; 118(1):232-40. DOI: 10.1002/cncr.26250. View